AskBio to Present Phase 1b Results Investigating AB-1005 (formerly AAV2-GDNF) as Treatment for Parkinson’s Disease at AD/PDTM 2023 International Conference on Alzheimer’s and Parkinson’s Diseases

—Preliminary data suggest that gene therapy via neurosurgical administration is generally safe, well tolerated and associated with enhanced mean putaminal coverage and clinical improvements— —Study uses one-time MRI-monitored surgery for delivery in patients with mild to moderate…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.